Fuji Pharma Co., Ltd. (4554.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 37.73B |
| Enterprise Value | 61.42B |
| P/E Ratio | 23.33 |
| PEG Ratio | -0.96 |
| Price/Sales Ratio | 1.05 |
| Price/Book Ratio | 1.13 |
| Enterprise/Revenue | 1.38 |
| Enterprise/EBITDA | 7.1 |
Fiscal Year
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.04 |
| Operating Margin | 0.12 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 51.68B |
| Revenue/Share | 2,282.61 |
| Gross Profit | 19.29B |
| EBITDA | 8.96B |
| Net Income | 3B |
| Diluted EPS | 122.93 |
Balance Sheet
| Total Cash | 10.89B |
| Total Cash/Share | 433.71 |
| Total Debt | 29.62B |
| Total Debt/Equity | 0.58 |
| Current Ratio | 1.68 |
| Book Value Per Share | 2,046.29 |
Price History
| 52-Week Change | 74.62 |
| 52-Week High | 2,559 |
| 52-Week Low | 1,307 |
| Moving Average 50 Days | 2,238.18 |
| Moving Average 200 Days | 1,981.31 |
Statistics
| Average Volume | 129,688 |
| Shares Outstanding | 26.12M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 48.5 |
| Trailing Annual Dividend Yield | 2.1 |
| Payout Ratio | 0.43 |
| Last Split Factor | 2:1 |
| Last Split Date | June 27, 2018 |
AD
